EUVIMEDEUVIMED entdecken
Crossref

Refining high-throughput in vitro–in vivo extrapolation modeling through incorporation of intestinal toxicokinetics

Evgenia Korol-Bexell iD, Anna S Jarnagin, Amanda Brennan iD, Jermaine Ford iD, Jackson Bounds iD, Denise M MacMillan iD, Michael F Hughes iD, Barbara A Wetmore iD

Toxicological Sciences · 2025

DOI: 10.1093/toxsci/kfaf105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicological Sciences, 2025. Verfasst von Evgenia Korol-Bexell und 7 weiteren Autor:innen. Beteiligte Einrichtung: Oak Ridge Institute for Science and Education, Oak Ridge, TN 37830, United States. Hauptthemen laut MEDLINE: Models, Biological, High-Throughput Screening Assays, Intestinal Mucosa, Intestines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: The United States Environmental Protection Agency, Office of Research and Development Chemical Safety for Sustainability National Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

New approach methods (NAMs) that combine high-throughput toxicity and toxicokinetic data have gained prominence as federal entities attempt to evaluate tens of thousands of commercial chemicals for human health hazards. In vitro–in vivo extrapolation employing a generic high-throughput toxicokinetic (HTTK) model to convert in vitro points of departure (POD) to human equivalent doses (i.e. PODNAMs) has proven successful in translating in vitro data to real-world exposures; however, conservative assumptions, including consideration of only hepatic metabolism, have resulted in PODNAMs that are 10- to 100-fold more conservative when compared to available in vivo-based PODs. This effort evaluates the impact of incorporating intestinal metabolism through consideration of cytochrome P450 monooxygenase isozyme 3A4 (CYP3A4), a cytochrome P450 isozyme responsible for over 80% of intestinal clearance. For 11 chemicals, intrinsic clearance rates were derived in human liver and intestinal microsomes with and without inhibition of CYP3A4 to quantitate relative CYP3A4 contribution. Physiologically based TK simulations were conducted using Simcyp Simulator to (i) recapitulate the HTTK approach and (ii) incorporate CYP3A4 contribution into the elimination model, which by extension incorporates intestinal clearance occurring via CYP3A4. CYP3A4 contribution ranged from 0% to 71% across the chemicals tested, and estimates of oral bioavailability, steady-state concentration, and fraction escaping gut metabolism typically decreased with increasing CYP3A4 involvement. Further, incorporation of in vitro PODs with this refined model showed a concomitant increase in PODNAMs, indicating that incorporating such information into HTTK provides more predictive risk-based prioritization of the commercial chemical space. Impact Statement The toxicokinetic model presented herein incorporates intestinal metabolism into an established generic toxicokinetic model designed for New Approach Method application. Considering CYP3A4 contribution as a surrogate for intestinal metabolism is sufficient and results in improved estimates of NAM-based POD for risk prioritization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Models, BiologicalHigh-Throughput Screening AssaysIntestinal MucosaIntestinesHumansToxicokineticsCytochrome P-450 CYP3AMicrosomes, LiverMicrosomesComputer Simulation

Stichwörter der Autor:innen

CYP3A4bioavailabilityin vitro–in vivo extrapolationintestinal metabolismnew approach methodsrisk assessmenttoxicokinetics

Substanzen

Cytochrome P-450 CYP3ACYP3A4 protein, human

Autor:innen und Institutionen

  • Oak Ridge Institute for Science and Education, Oak Ridge, TN 37830, United States.
  • Office of Research and Development, Center for Computational Toxicology and Exposure, Chemical Characterization and Exposure Division, United States Environmental Protection Agency, Research Triangle Park, NC 27711, Uni…
  • Oak Ridge Associated Universities, Oak Ridge, TN 37830, United States.

ORCID-Profile: Evgenia Korol-Bexell, Amanda Brennan, Jermaine Ford, Jackson Bounds, Denise M MacMillan, Michael F Hughes, Barbara A Wetmore

Förderung

  • The United States Environmental Protection Agency
  • Office of Research and Development Chemical Safety for Sustainability National Research Program

Zitieren

APA

Korol-Bexell, E., Jarnagin, A. S., Brennan, A., Ford, J., Bounds, J., MacMillan, D. M., Hughes, M. F., & Wetmore, B. A. (2025). Refining high-throughput in vitro–in vivo extrapolation modeling through incorporation of intestinal toxicokinetics. Toxicological Sciences. https://doi.org/10.1093/toxsci/kfaf105

Vancouver

Korol-Bexell E, Jarnagin AS, Brennan A, Ford J, Bounds J, MacMillan DM, et al. Refining high-throughput in vitro–in vivo extrapolation modeling through incorporation of intestinal toxicokinetics. Toxicological Sciences. 2025. doi:10.1093/toxsci/kfaf105

BibTeX
@article{KorolBexell2025,
  author = {Korol-Bexell, Evgenia and Jarnagin, Anna S and Brennan, Amanda and Ford, Jermaine and Bounds, Jackson and MacMillan, Denise M and Hughes, Michael F and Wetmore, Barbara A},
  title = {Refining high-throughput in vitro–in vivo extrapolation modeling through incorporation of intestinal toxicokinetics},
  journal = {Toxicological Sciences},
  year = {2025},
  doi = {10.1093/toxsci/kfaf105}
}
Kostenlos starten →